Ignite Creation Date:
2024-05-06 @ 7:17 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05958199
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2023-06-23
Brief Title:
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2B7-H7
Sponsor:
NextPoint Therapeutics Inc
Organization:
NextPoint Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Malignant Neoplasm |
Keywords:
| Name | View |
|---|---|
| Dose expansion | View |
| B7-H7HHLA2 | View |
| Non-small cell lung carcinoma | View |
| renal cell carcinoma | View |
| colorectal carcinoma | View |
| cholangiocarcinoma | View |
| pancreatic cancer | View |
| urothelial carcinoma | View |
| gastric gastroesophageal carcinoma | View |
| triple negative breast carcinoma | View |
| endometrial carcinoma | View |
| cervical cancer | View |
| osteosarcoma | View |
| prostate cancer | View |
| RECIST | View |
| Dose escalation | View |